Simultaneous determination of new-generation antidepressants in plasma by gas chromatography-mass spectrometry

Forensic Toxicology

Volumn 31, Issue 1, 2013, Pages 124-132

  Pietracci, Elisa ^a   Bermejo, Ana María ^b   Álvarez, Iván ^b   Cabarcos, Pamela ^b   Balduini, Walter ^a   Tabernero, María Jesús ^b  

^a UNIVERSITY OF URBINO   (Italy)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Antidepressant SSRIs; GC MS; LLE; Olanzapine; Plasma

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; CLONAZEPAM; DULOXETINE; FLUOXETINE; FLURAZEPAM; IMIPRAMINE; MIRTAZAPINE; NORFENAZINE; NORFLUOXETINE; OLANZAPINE; OXCARBAZEPINE; PAROXETINE; SERTRALINE; TERT BUTYL METHYL ETHER; TRANXILLIUM; UNCLASSIFIED DRUG; VANDRAL; VENLAFAXINE;

ACCURACY; ADULT; AGED; ANALYTIC METHOD; CALIBRATION; CLINICAL ARTICLE; CONFERENCE PAPER; CORRELATION COEFFICIENT; DRUG BLOOD LEVEL; DRUG DETERMINATION; FEMALE; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID LIQUID EXTRACTION; MALE; MASS FRAGMENTOGRAPHY; PRIORITY JOURNAL; QUALITATIVE RESEARCH; QUANTITATIVE STUDY; REPRODUCIBILITY; SENSITIVITY ANALYSIS;

EID: 84872680050     PISSN: 18608965     EISSN: 18608973     Source Type: Journal    
DOI: 10.1007/s11419-012-0152-7     Document Type: Article

References (25)

1. World Health Organization (WHO) (2012) http://www.who.int/mental-health/ management/depression/definition/en/
2. Federazione Nazionale Unitaria Titolari di Farmacia (FEDERFARMA) (2012). http://www.federfarma.it/
3. Sussman N (2003) SNRIs versus SSRIs: mechanisms of action in treating depression and painful physical symptoms. Prim Care Companion J Clin Psychiatry 5(suppl 7):19-26
4. Samalin L, Charpeaud T, Guillaume S (2011) Guidelines for the biological treatment of bipolar depression. Encephale 37(Suppl 3):S218-S223
5. Pillarella J, Higashi A, Alexander GC, Conti R (2012) Trends in use of second-generation antipsychotics for treatment of bipolar disorder in the United States, 1998-2009. Psychiatr Serv 63(1):83-6
6. Moncrieff J, Kirsch I (2005) Efficacy of antidepressants in adults. BMJ 331:155-159
7. Healy D (2006) Did regulators fail over selective serotonin reuptake inhibitors? BMJ 333:92-95 (Pubitemid 44406818)
8. Hammad TA, Laughren T, Racoosin J (2006) Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 63:332-339 (Pubitemid 43345358)
9. Hetrick SE, Merry SN, McKenzie J, et al (2007) Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents. Cochrane Database Syst Rev; Issue 3. No. CD004851
10. Henry A, Kisicki MD, Varley C (2011) Efficacy and safety of antidepressant drug treatment in children and adolescents. Mol Psychiatry. doi: 10.1038/mp.2011.150
11. Gunnar T, Mykkänen S, Ariniemi K, Lillsunde P (2004) Validated semiquantitative/quantitative screening of 51 drugs in whole blood as silylated derivatives by gas chromatography-selected ion monitoring mass spectrometry and gas chromatography electron capture detection. J Chromatogr B 806:205-219 (Pubitemid 38686509)
12. Salgado-Petinal C, Lamas JP, Garcia-Jares C, Llompart M, Cela R (2005) Rapid screening of selective serotonin re-uptake inhibitors in urine samples using solid-phase microextraction gas chromatography-mass spectrometry. Anal Bioanal Chem 382:1351-1359 (Pubitemid 41117844)
13. Wille SMR, Maudens KE, Van Peteghem CH, Lambert WE (2005) Development of a solid phase extraction for 13 'new' generation antidepressants and their active metabolites for gas chromatographic-mass spectrometric analysis. J Chromatogr A 1098:19-29 (Pubitemid 41682405)
14. Wille SMR, De Letter EA, Piette MHA, Van Overschelde LK, Van Peteghem CH, Lambert WE (2009) Determination of antidepressants in human postmortem blood, brain tissue, and hair using gas chromatography-mass spectrometry. Int J Legal Med 123(6):451-458
15. Josefsson M, Romana M, Skoghc E, Dahl ML (2010) Liquid chromatography/tandem mass spectrometry method for determination of olanzapine and N-desmethylolanzapine in human serum and cerebrospinal fluid. J Pharm Biomed Anal 53:576-582
16. López-Guarnido O, Alvarez I, Gil F, Rodrigo L, Cataño HC, Bermejo A, Tabernero MJ, Pla A, Hernández A (2012) Hair testing for cocaine and metabolites by GC/MS: criteria to quantitatively assess cocaine use. J Appl Toxicol (wileyonlinelibrary.com). doi: 10.1002/jat.2741
17. Moffat AC, Osselton MD, Widdop B, Watts J (2011) Clarke's analysis of drugs and poisons, 4th edn. ISBN 978 0 85369 711 4
18. FDA: US Food and Drug Administration (2001) http://www.fda.gov/cder/ guidance/index.htm
19. Wille SMR, Van Hee P, Neels HM, Van Peteghem CH, Lambert WE (2007) Comparison of electron and chemical ionization modes by validation of a quantitative gas chromatographic-mass spectrometric assay of new generation antidepressants and their active metabolites in plasma. J Chromatogr A 1176:236-245 (Pubitemid 350193236)
20. Paterson S, Cordero R, Burlinson S (2004) Screening and semi-quantitative analysis of post mortem blood for basic drugs using gas chromatography/ion trap mass spectrometry. J Chromatogr B 813:323-330 (Pubitemid 39535461)
21. Lamas JP, Salgado-Petinal C, García-Jares C, Llompart M, Cela R, Gómez M (2004) Solid-phase microextraction-gas chromatography-mass spectrometry for the analysis of selective serotonin reuptake inhibitors in environmental water. J Chromatogr A 1046:241-247 (Pubitemid 39044447)
22. Matyash V, Liebisch G, Kurzchalia TV, Shevchenko A, Schwudke D (2008) Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J Lipid Res 49(5):1137-1146
23. Nevado JB, Lierena MJV, Cabanillas GG, Robledo VR, Buitrago S (2006) Sensitive capillary GC-MS-SIM determination of selective serotonin reuptake inhibitors: reliability evaluation by validation and robustness study. J Sep Sci 29:103-113 (Pubitemid 43203194)
24. Compton R, Spiller HA, Bosse GM (2005) Fatal fluoxetine ingestion with postmortem blood concentrations. Clin Tox 43(4):277-279 (Pubitemid 41073026)
25. Dahl B, Crouch BI, Rollins D (1996) Death from venlafaxine overdose (Effexor). Clin Tox 34:557